Logo image of UPXI

UPEXI INC (UPXI) Stock Fundamental Analysis

NASDAQ:UPXI - Nasdaq - US39959A2050 - Common Stock - Currency: USD

13.64  +0.87 (+6.81%)

After market: 13.45 -0.19 (-1.39%)

Fundamental Rating

2

Overall UPXI gets a fundamental rating of 2 out of 10. We evaluated UPXI against 35 industry peers in the Personal Care Products industry. UPXI may be in some trouble as it scores bad on both profitability and health. UPXI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

UPXI had negative earnings in the past year.
UPXI had a negative operating cash flow in the past year.
In the past 5 years UPXI reported 4 times negative net income.
In multiple years UPXI reported negative operating cash flow during the last 5 years.
UPXI Yearly Net Income VS EBIT VS OCF VS FCFUPXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -130.02%, UPXI is not doing good in the industry: 91.43% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -605.68%, UPXI is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -130.02%
ROE -605.68%
ROIC N/A
ROA(3y)-43.82%
ROA(5y)-40.96%
ROE(3y)-143.38%
ROE(5y)-551.09%
ROIC(3y)N/A
ROIC(5y)N/A
UPXI Yearly ROA, ROE, ROICUPXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

Looking at the Gross Margin, with a value of -45.37%, UPXI is doing worse than 91.43% of the companies in the same industry.
UPXI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for UPXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -45.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y0.94%
UPXI Yearly Profit, Operating, Gross MarginsUPXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
UPXI has less shares outstanding than it did 1 year ago.
UPXI has less shares outstanding than it did 5 years ago.
UPXI has a worse debt/assets ratio than last year.
UPXI Yearly Shares OutstandingUPXI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
UPXI Yearly Total Debt VS Total AssetsUPXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

UPXI has an Altman-Z score of 13.45. This indicates that UPXI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.45, UPXI belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
UPXI has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.35, UPXI perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 13.45
ROIC/WACCN/A
WACC9.02%
UPXI Yearly LT Debt VS Equity VS FCFUPXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

UPXI has a Current Ratio of 0.58. This is a bad value and indicates that UPXI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of UPXI (0.58) is worse than 91.43% of its industry peers.
UPXI has a Quick Ratio of 0.58. This is a bad value and indicates that UPXI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.36, UPXI is doing worse than 91.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.36
UPXI Yearly Current Assets VS Current LiabilitesUPXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for UPXI have decreased strongly by -1756.90% in the last year.
The Revenue for UPXI has decreased by -109.41% in the past year. This is quite bad
UPXI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 63.73% yearly.
EPS 1Y (TTM)-1756.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-524.59%
Revenue 1Y (TTM)-109.41%
Revenue growth 3Y2.56%
Revenue growth 5Y63.73%
Sales Q2Q%-81.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y30.61%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UPXI Yearly Revenue VS EstimatesUPXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UPXI Yearly EPS VS EstimatesUPXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UPXI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UPXI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UPXI Price Earnings VS Forward Price EarningsUPXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UPXI Per share dataUPXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UPXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UPEXI INC

NASDAQ:UPXI (5/22/2025, 4:42:59 PM)

After market: 13.45 -0.19 (-1.39%)

13.64

+0.87 (+6.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-12 2025-05-12
Earnings (Next)N/A N/A
Inst Owners1.18%
Inst Owner Change-13.46%
Ins Owners22.1%
Ins Owner Change0%
Market Cap508.64M
Analysts43.33
Price Target25.5 (86.95%)
Short Float %1.17%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-75.33%
Min Revenue beat(2)-77.19%
Max Revenue beat(2)-73.46%
Revenue beat(4)0
Avg Revenue beat(4)-125.48%
Min Revenue beat(4)-315.64%
Max Revenue beat(4)-35.64%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 135.17
P/tB 187.52
EV/EBITDA N/A
EPS(TTM)-21.83
EYN/A
EPS(NY)-6.94
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS-0.29
BVpS0.1
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -130.02%
ROE -605.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -45.37%
FCFM N/A
ROA(3y)-43.82%
ROA(5y)-40.96%
ROE(3y)-143.38%
ROE(5y)-551.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y0.94%
F-Score2
Asset Turnover-0.61
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.07%
Cap/Sales -5.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.36
Altman-Z 13.45
F-Score2
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)81.08%
Cap/Depr(5y)139.5%
Cap/Sales(3y)9.46%
Cap/Sales(5y)12.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1756.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-524.59%
EPS Next Y30.61%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-109.41%
Revenue growth 3Y2.56%
Revenue growth 5Y63.73%
Sales Q2Q%-81.65%
Revenue Next Year8.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year235.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-199.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.95%
OCF growth 3YN/A
OCF growth 5YN/A